Cantharis Pellet
Product Images NDC 76472-3010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cantharis (NDC 76472-3010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sevene Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Page3 Label Ollois Common

Page3 Label Ollois Common
This is a description about information provided on a product called Drug Facts. It contains an inactive ingredient that is Organic Sucrose. There are also homeopathic dilutions represented by the letters C, K, CK & X. The text includes a contact email for questions or comments. The product is distributed by SEVENE USA Inc. and a phone number is provided. Additionally, the text offers a brief tutorial on how to dispense pellets. Website for additional information is provided as ollois.com.*
FDA Label Image

Label Ollois Cantharis 200ck Page1

Label Ollois Cantharis 200ck Page1
This is a homeopathic medicine product description for Cantharis 200ck, with uses traditionally for burns, blisters, bladder irritation, and inflammation. It comes with approximately 80 pellets weighing about 4g and is lactose-free. No FDA evaluation, and the claims are solely based on traditional homeopathic practice, not accepted medical evidence. Drug facts and directions for use available by pulling.*
FDA Label Image

Label Ollois Cantharis 200ck Page2

Label Ollois Cantharis 200ck Page2
This is a drug labeled "Cantharis 200CK" that is used to treat burns, blisters, bladder inflammation, and irritation. The user is advised to dissolve 5 pellets under the tongue three times a day until the symptoms disappear or as instructed by a doctor. They are also instructed to discontinue use and contact a doctor if the symptoms persist or worsen after three days. Pregnant or breastfeeding women should consult with their healthcare provider before using the drug. The drug should be kept out of reach of children, and medical attention should be sought in case of an overdose. The drug is packaged with an organic verification seal issued by Alpes Controle in 2021.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.